메뉴 건너뛰기
The Lancet
Volumn 376, Issue 9755, 2010, Pages 1826-
Licence for Botox in so-called chronic migraine - Response from MHRA
Author keywords

[No Author keywords available]
Indexed keywords

BOTULINUM TOXIN A;
EID: 78649467518     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)62166-6     Document Type: Letter
Times cited : (1)
References (2)
  • 1
    • 77953194100 scopus 로고    scopus 로고
    • OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
    • SK Aurora, DW Dodick, CC Turkel OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 2010 793 803
    • (2010) Cephalalgia , vol.30 , pp. 793-803
    • Aurora, S.K.1    Dodick, D.W.2    Turkel, C.C.3
  • 2
    • 77953223552 scopus 로고    scopus 로고
    • OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
    • HC Diener, DW Dodick, SK Aurora OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 2010 804 814
    • (2010) Cephalalgia , vol.30 , pp. 804-814
    • Diener, H.C.1    Dodick, D.W.2    Aurora, S.K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.